H.C. Wainwright analyst Douglas Tsao raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $50.00 (from $36.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE